Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antibody Structure01:10

Antibody Structure

57.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
57.5K
The Two-State Receptor Model01:29

The Two-State Receptor Model

1.8K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.8K
Antibody Structure and Classes01:25

Antibody Structure and Classes

645
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
645
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Enzyme Inhibition01:30

Enzyme Inhibition

77.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Non-Releasers in the Basophil Activation Test: A Roadmap for the Correct Reporting and Interpretation.

Allergy·2026
Same author

Emerging diagnostic and therapeutic opportunities in food allergy.

Frontiers in immunology·2026
Same author

Novel Biomarkers and Diagnostic Tools in Food Allergy.

Allergy·2025
Same author

High-affinity omalizumab variants with optimized disruptive potency prevent anaphylaxis in vivo.

The Journal of allergy and clinical immunology·2025
Same author

Age-Related Increase in Anaphylaxis Severity Is Associated With Enhanced Sensitivity to Allergic Mediators.

Allergy·2025
Same author

IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and aging.

iScience·2025

相关实验视频

Updated: May 9, 2025

Detection of True IgE-expressing Mouse B Lineage Cells
09:40

Detection of True IgE-expressing Mouse B Lineage Cells

Published on: December 1, 2014

10.9K

对IgE受体相互作用和破坏性抑制的结构和功能洞察

Alexander Eggel1,2, Theodore S Jardetzky3

  • 1Department for BioMedical Research, University of Bern, Bern, Switzerland.

Immunological reviews
|April 30, 2025
PubMed
概括
此摘要是机器生成的。

针对免疫球蛋白E (IgE) 的新疗法利用其独特的结构灵活性来破坏过敏反应. 这些先进的生物药物通过向自由和结合IgE来提供更快,更广泛的过敏治疗.

关键词:
CD23 CD23 CD23 CD23 CD23 CD23 CD23 CD23 CD23 CD23 CD23 CD23 CD23在DARP中,insins是弗塞里斯 (FcεRI) 的意思在 IgE 中,IgE 是它们是IgE受体.过敏是一种过敏.具有破坏性的IgE抑制剂.促进了分离的过程.轻易使用Zumab.在Omalizumab上使用.

更多相关视频

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
04:15

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

1.6K
A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.1K

相关实验视频

Last Updated: May 9, 2025

Detection of True IgE-expressing Mouse B Lineage Cells
09:40

Detection of True IgE-expressing Mouse B Lineage Cells

Published on: December 1, 2014

10.9K
Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
04:15

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

1.6K
A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.1K

科学领域:

  • 免疫学 免疫学 免疫学
  • 结构生物学 结构生物学
  • 过敏研究 研究过敏

背景情况:

  • 免疫球蛋白E (IgE) 对于防御至关重要,但对过敏反应至关重要.
  • 免疫细胞上的IgE与FcεRI和CD23受体相互作用,增强2型免疫.
  • IgE的形状灵活性决定了受体的结合和功能.

研究的目的:

  • 审查IgE及其受体的结构和机制见解如何为下一代抗IgE疗法提供信息.
  • 要突出"破坏性"IgE抑制剂的发展,这些抑制剂可以拆卸IgE:FcεRI复合体.
  • 讨论这些新生物药物对于更快,更有效的过敏治疗的潜力.

主要方法:

  • 对IgE构造和受体相互作用的结构研究的分析.
  • 审查现有的抗IgE生物药物 (例如,奥马利祖马布) 和它们的局限性.
  • 检查新的"破坏性"IgE抑制剂及其作用机制.

主要成果:

  • 对于有选择性的FcεRI或CD23结合,IgE采用不同的构造 (开放/关闭).
  • 目前的抗IgE疗法主要是中和自由IgE,在向结合IgE方面存在局限性.
  • 新的"破坏性"抑制剂积极分解IgE:FcεRI复合体,使其能够快速降低敏感性.

结论:

  • 了解IgE形态动态是设计先进抗IgE疗法的关键.
  • 下一代"破坏性"IgE抑制剂具有更快开始和更广泛有效性的潜力.
  • 这些多功能生物药物代表了IgE向过敏治疗的新时代.